Social Media Ideas for Experimental Treatment

KHL Foundation Reports the Likely First Human Partial Epigenetic Reprogramming Treatments

The first human application of partial epigenetic reprogramming of aged tissues, using adeno-associated viral (AAV) vectors, was not in fact the first patient dosed in the recently...

First-in-class treatment for early Parkinson’s shows ‘remarkable’ results

A new first-in-class treatment for Parkinson’s disease, designed to get past the brain’s protective barrier, was shown to be safe and well-tolerated in an early clinical trial, and...

Engineered Exosomes as a Treatment for Alzheimer's Disease

Exosomes are one category of extracellular vesicle secreted by cells, a membrane-wrapped package of molecules, one complex component of the extensive, incompletely mapped communica...

New treatment approach for children with short-limbed dwarfism

A phase 3 trial is showing "a potentially giant step forward" in treating children with achondroplasia, UCLA Health's Dr. Isidro B. Salusky wrote in an editorial published in the N...

Stanford blood cancer transplant therapy reaches first commercial patient

In a remarkable advancement, Stanford researchers have unveiled Orca-T therapy, which has recently received FDA approval. After two decades of rigorous development, this innovative...

Remedy tested to fight Congo's deadliest Ebola outbreak

RWAMPARA, Congo — More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo, in what experts have described as a crit...

Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment. The trial began in July and is one of s...

Oral hemophilia A treatment shows promise in preclinical studies

Inno8, a potential oral treatment to prevent bleeds in people with hemophilia A, appears more potent and long-lasting than currently available injectable treatments in preclinical...

First patient dosed in clinical trial of oral treatment for Parkinson’s

The first patient has been dosed in Mission Therapeutics’ Phase 1b clinical trial of MTX325, an oral treatment for Parkinson’s disease. With several locations open in the U.K., Fra...

Germany treats 1st patient with CRISPR therapy since approval

A patient in Germany has been successfully treated with a drug based on CRISPR gene-editing technology for the first time since the therapy was approved, the Charité medical school...

Health study shows the efficacy of drug treatments

Dallas researchers seeking patients for breast cancer treatment clinical trial

A clinical trial going on now at UT Southwestern Medical Center in Dallas could lead to a new treatment option for some breast cancer patients. And more women are needed as the...

Montana Is Trying To Break the FDA's Monopoly on Experimental Treatments

Montana’s expanded right-to-try program has cleared its first therapy: a sound-and-antihistamine regimen to reverse hearing loss.

Inside the study for a remedy to fight Congo's deadliest Ebola outbreak

More than 250 participants have been enrolled in a trial for a drug that could stop them from contracting Ebola in Congo

Experimental Arrowhead RNAi drug hints at Alzheimer’s benefit

In a first, a subcutaneously administered RNA interference medicine crossed into the brain and plummeted levels of a protein implicated in the disease.

The Christ Hospital seeks volunteers for single-shot treatment that may fix high cholesterol

A Phase 2 clinical trial, "PULSE 1," is testing a one-time injection that researchers say could reduce LDL cholesterol by at least 60%.

Chemogenetics: Rewriting the Rules of Disability Care

Chemogenetics uses engineered receptors and inert drugs to switch neurons on or off, opening reversible new treatments for epilepsy, pain and paralysis

Landmark China trial gets 84% efficacy in treating cancer with cue from waste water tech

For patients with advanced, metastatic cancer that has progressed despite systemic therapy – options remain critically limited. Now, Chinese scientists are pointing to an unconvent...

Experimental therapy K-9 restores lost vision and mobility in MS mice

An experimental therapy called kamuvudine-9 (K-9) reversed established paralysis and vision loss in a mouse model of multiple sclerosis (MS), offering hope for treatments that can...

New injectable treatment helps the brain rebuild after stroke

Duke researchers developed an injectable scaffold that helped stroke-damaged brains grow new blood vessels, support nerve regrowth, and recover movement in mice. The treatment appe...

Two Immune Drugs Combined Achieve Dramatic Recovery in Stubborn Psoriatic Arthritis Case

A 35-year-old man who spent sixteen months shuttling between three different diagnoses and four failed therapies has emerged as a striking demonstration of what dual-targeted immun...

More options, better odds: the changing prostate cancer treatment landscape

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space. The post More options, better odds: the changing pros...

This Experimental Treatment Could Make Wegovy and Ozempic Even More Effective

A new study suggests an RNA-based therapy could help semaglutide target more fat while reducing the lean-muscle loss associated with GLP-1 weight loss.

When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients

Discover Andy Brown's long and arduous journey battling a type of non-Hodgkin lymphoma and how a clinical trial altered his treatment outlook. The post When every treatment counts:...